|
US8030343B2
(en)
*
|
2000-06-08 |
2011-10-04 |
Celgene Corporation |
Pharmaceutically active isoindoline derivatives
|
|
US7311905B2
(en)
*
|
2002-02-13 |
2007-12-25 |
Anthrogenesis Corporation |
Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
|
|
EP2305795B1
(en)
|
2000-12-06 |
2019-07-03 |
Celularity, Inc. |
Method of collecting placental stem cells
|
|
AU2002243980B2
(en)
|
2001-02-14 |
2007-08-23 |
Robert J. Hariri |
Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells
|
|
US7498171B2
(en)
*
|
2002-04-12 |
2009-03-03 |
Anthrogenesis Corporation |
Modulation of stem and progenitor cell differentiation, assays, and uses thereof
|
|
BR0315316A
(pt)
|
2002-10-15 |
2005-08-16 |
Celgene Corp |
Métodos de tratar, prevenir ou controlar uma sìndrome mielodisplásica, e de reduzir ou evitar um efeito adverso associado com a administração de um segundo ingrediente ativo em um paciente sofrendo de uma sìndrome mielodisplásica, composição farmacêutica, forma de dosagem unitária, e, kit
|
|
CA2505534A1
(en)
*
|
2002-11-26 |
2004-06-10 |
Anthrogenesis Corporation |
Cytotherapeutics, cytotherapeutic units and methods for treatments using them
|
|
US20050143344A1
(en)
*
|
2003-12-30 |
2005-06-30 |
Zeldis Jerome B. |
Methods and compositions using immunomodulatory compounds for the treatment and management of central nervous system disorders or diseases
|
|
KR20070002067A
(ko)
*
|
2004-03-26 |
2007-01-04 |
셀진 코포레이션 |
줄기 세포 은행의 제공 시스템 및 제공 방법
|
|
WO2005110085A2
(en)
*
|
2004-04-14 |
2005-11-24 |
Celgene Corporation |
Use of selective cytokine inhibitory drugs in myelodysplastic syndromes
|
|
US7244759B2
(en)
*
|
2004-07-28 |
2007-07-17 |
Celgene Corporation |
Isoindoline compounds and methods of making and using the same
|
|
BRPI0519030A2
(pt)
*
|
2004-12-13 |
2008-12-23 |
Celgene Corp |
mÉtodos de tratamento, prevenÇço, ou controle de inflamaÇço das vias aÉreas e de uma doenÇa ou distérbio das vias aÉreas ou pulmonar, e, composiÇço farmacÊutica
|
|
DK1907373T3
(da)
*
|
2005-06-30 |
2013-02-04 |
Celgene Corp |
Fremgangsmåder til fremstillingen af 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindolin-1,3-dionforbindelser
|
|
JP2008544818A
(ja)
*
|
2005-06-30 |
2008-12-11 |
アントフロゲネシス コーポレーション |
胎盤由来コラーゲンバイオ線維を用いた鼓膜の修復
|
|
US20070021762A1
(en)
*
|
2005-07-13 |
2007-01-25 |
Qing Liu |
Ocular plug formed from placenta derived collagen biofabric
|
|
EP1919500A2
(en)
*
|
2005-07-13 |
2008-05-14 |
Anthrogenesis Corporation |
Treatment of leg ulcers using placenta derived collagen biofabric
|
|
US20070066512A1
(en)
*
|
2005-09-12 |
2007-03-22 |
Dominique Verhelle |
Methods and compositions using immunomodulatory compounds for the treatment of disorders associated with low plasma leptin levels
|
|
US7878970B2
(en)
|
2005-09-28 |
2011-02-01 |
Boston Scientific Scimed, Inc. |
Apparatus and method for suspending a uterus
|
|
CA2624916A1
(en)
*
|
2005-10-13 |
2007-04-26 |
Anthrogenesis Corporation |
Production of oligodendrocytes from placenta-derived stem cells
|
|
EP1957633B1
(en)
|
2005-10-13 |
2013-12-18 |
Anthrogenesis Corporation |
Immunomodulation using placental stem cells
|
|
US9598669B2
(en)
|
2005-12-29 |
2017-03-21 |
Anthrogenesis Corporation |
Composition for collecting placental stem cells and methods of using the composition
|
|
EP2471903B1
(en)
|
2005-12-29 |
2018-02-14 |
Anthrogenesis Corporation |
Placental stem cell populations
|
|
WO2007079184A2
(en)
*
|
2005-12-29 |
2007-07-12 |
Anthrogenesis Corporation |
Co-culture of placental stem cells and stem cells from a second source
|
|
US9144483B2
(en)
|
2006-01-13 |
2015-09-29 |
Boston Scientific Scimed, Inc. |
Placing fixation devices
|
|
EP1998711B1
(en)
|
2006-03-16 |
2013-12-11 |
Boston Scientific Limited |
Apparatus for treatment of pelvic conditions
|
|
US20080064876A1
(en)
*
|
2006-05-16 |
2008-03-13 |
Muller George W |
Process for the preparation of substituted 2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione
|
|
TW200806625A
(en)
*
|
2006-05-26 |
2008-02-01 |
Astrazeneca Ab |
Therapeutic compounds
|
|
US7993918B2
(en)
|
2006-08-04 |
2011-08-09 |
Anthrogenesis Corporation |
Tumor suppression using placental stem cells
|
|
US8105634B2
(en)
*
|
2006-08-15 |
2012-01-31 |
Anthrogenesis Corporation |
Umbilical cord biomaterial for medical use
|
|
WO2008042441A1
(en)
*
|
2006-10-03 |
2008-04-10 |
Anthrogenesis Corporation |
Use of umbilical cord biomaterial for ocular surgery
|
|
WO2008060377A2
(en)
|
2006-10-04 |
2008-05-22 |
Anthrogenesis Corporation |
Placental or umbilical cord tissue compositions
|
|
NZ612094A
(en)
|
2006-10-06 |
2015-02-27 |
Anthrogenesis Corp |
Native (telopeptide) placental collagen compositions
|
|
KR20090076989A
(ko)
|
2006-10-23 |
2009-07-13 |
안트로제네시스 코포레이션 |
태반 줄기세포군으로 뼈의 결함을 치료하기 위한 방법과 조성물
|
|
PL2120977T3
(pl)
|
2007-02-12 |
2013-12-31 |
Anthrogenesis Corp |
Leczenie chorób zapalnych z zastosowaniem łożyskowych komórek macierzystych
|
|
JP2010518812A
(ja)
|
2007-02-12 |
2010-06-03 |
アンスロジェネシス コーポレーション |
接着性胎盤幹細胞由来の肝細胞および軟骨細胞、ならびにｃｄ３４＋、ｃｄ４５−胎盤幹細胞の濃縮細胞集団
|
|
US9200253B1
(en)
|
2007-08-06 |
2015-12-01 |
Anthrogenesis Corporation |
Method of producing erythrocytes
|
|
US8263065B2
(en)
|
2007-09-28 |
2012-09-11 |
Anthrogenesis Corporation |
Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
|
|
WO2009073146A2
(en)
*
|
2007-11-29 |
2009-06-11 |
Celgene Corporation |
Use of immunomodulatory compounds for the treatment of transverse myelitis, multiple sclerosis, and other disorders
|
|
CA2710196A1
(en)
|
2007-12-20 |
2009-07-09 |
Celgene Corporation |
Use of micro-rna as a biomarker of immunomodulatory drug activity
|
|
US8430807B2
(en)
|
2007-12-28 |
2013-04-30 |
Boston Scientific Scimed, Inc. |
Devices and methods for treating pelvic floor dysfunctions
|
|
US9078728B2
(en)
|
2007-12-28 |
2015-07-14 |
Boston Scientific Scimed, Inc. |
Devices and methods for delivering female pelvic floor implants
|
|
WO2009105256A2
(en)
*
|
2008-02-20 |
2009-08-27 |
Celgene Corporation |
Method of treating cancer by administering an immunomodulatory compound in combination with a cd40 antibody or cd40 ligand
|
|
EP3172963B1
(en)
|
2008-08-20 |
2019-02-06 |
Celularity, Inc. |
Improved cell composition and methods of making the same
|
|
DK2331109T3
(da)
|
2008-08-22 |
2013-09-08 |
Anthrogenesis Corp |
Fremgangsmåder og sammensætninger til behandling af knogledefekter med placentale cellepopulationer
|
|
RU2562154C2
(ru)
|
2008-11-19 |
2015-09-10 |
Антродженезис Корпорейшн |
Амниотические адгезивные клетки
|
|
US20120149716A1
(en)
|
2009-02-10 |
2012-06-14 |
Zeldis Jerome B |
Methods of using and compositions comprising pde4 modulators for treatment, prevention and management of tuberculosis
|
|
RU2642988C2
(ru)
|
2009-03-25 |
2018-01-29 |
Антродженезис Корпорейшн |
Супрессия опухолей с использованием полученных из плаценты человека промежуточных естественных киллерных клеток и иммуномодулирующих соединений
|
|
US9125716B2
(en)
|
2009-04-17 |
2015-09-08 |
Boston Scientific Scimed, Inc. |
Delivery sleeve for pelvic floor implants
|
|
EP2436387B1
(en)
|
2009-05-25 |
2018-07-25 |
Celgene Corporation |
Pharmaceutical composition comprising crbn for use in treating a disease of the cerebral cortex
|
|
AU2013263763B2
(en)
*
|
2009-06-18 |
2016-05-19 |
Concert Pharmaceuticals, Inc. |
Deuterated isoindoline-1,3-dione derivatives as PDE4 and TNF-alpha inhibitors
|
|
RS53357B
(sr)
|
2009-06-18 |
2014-10-31 |
Concert Pharmaceuticals Inc. |
Deuterijumski derivati izoindolin-1,3-diona kao inhibitori pde4 i tnf-alfa
|
|
EP3190179A1
(en)
|
2009-07-02 |
2017-07-12 |
Anthrogenesis Corporation |
Method of producing erythrocytes without feeder cells
|
|
CN102639498A
(zh)
|
2009-10-09 |
2012-08-15 |
细胞基因公司 |
制备2-(1-苯乙基)异吲哚啉-1-酮化合物的方法
|
|
MX337566B
(es)
|
2010-01-05 |
2016-03-10 |
Celgene Corp |
Combinación de un compuesto inmunomodulador y una artemisinina o un derivado de ésta para tratar cáncer.
|
|
KR20120115602A
(ko)
|
2010-01-26 |
2012-10-18 |
안트로제네시스 코포레이션 |
태반 줄기 세포를 사용한 골 관련 암의 치료
|
|
SG10201501062SA
(en)
|
2010-02-11 |
2015-04-29 |
Celgene Corp |
Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
|
|
PT2556145T
(pt)
|
2010-04-07 |
2016-10-25 |
Anthrogenesis Corp |
Angiogénese usando células estaminais placentárias
|
|
EP2555783A1
(en)
|
2010-04-08 |
2013-02-13 |
Anthrogenesis Corporation |
Treatment of sarcoidosis using placental stem cells
|
|
CN103026229B
(zh)
|
2010-06-15 |
2016-03-30 |
细胞基因公司 |
用于治疗银屑病的生物标志物
|
|
KR20230096132A
(ko)
|
2010-07-13 |
2023-06-29 |
셀룰래리티 인코포레이티드 |
천연 킬러 세포의 생성 방법
|
|
US8911348B2
(en)
|
2010-09-02 |
2014-12-16 |
Boston Scientific Scimed, Inc. |
Pelvic implants and methods of implanting the same
|
|
CN106008313B
(zh)
*
|
2010-12-22 |
2018-11-13 |
康塞特医药品有限公司 |
取代的异吲哚啉-1,3二酮衍生物
|
|
US8969315B2
(en)
|
2010-12-31 |
2015-03-03 |
Anthrogenesis Corporation |
Enhancement of placental stem cell potency using modulatory RNA molecules
|
|
AU2012205809B2
(en)
*
|
2011-01-10 |
2015-09-10 |
Amgen (Europe) GmbH |
Phenethylsulfone isoindoline derivatives as inhibitors of PDE 4 and/or cytokines
|
|
WO2012097116A2
(en)
*
|
2011-01-14 |
2012-07-19 |
Celgene Corporation |
Isotopologues of isoindole derivatives
|
|
JP2014517915A
(ja)
|
2011-04-18 |
2014-07-24 |
セルジーン コーポレイション |
多発性骨髄腫治療のためのバイオマーカー
|
|
US9365640B2
(en)
|
2011-04-29 |
2016-06-14 |
Celgene Corporation |
Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor
|
|
US9040035B2
(en)
|
2011-06-01 |
2015-05-26 |
Anthrogenesis Corporation |
Treatment of pain using placental stem cells
|
|
US9938269B2
(en)
|
2011-06-30 |
2018-04-10 |
Abbvie Inc. |
Inhibitor compounds of phosphodiesterase type 10A
|
|
US9925221B2
(en)
|
2011-09-09 |
2018-03-27 |
Celularity, Inc. |
Treatment of amyotrophic lateral sclerosis using placental stem cells
|
|
US9168120B2
(en)
|
2011-09-09 |
2015-10-27 |
Boston Scientific Scimed, Inc. |
Medical device and methods of delivering the medical device
|
|
ES2872967T3
(es)
|
2012-06-29 |
2021-11-03 |
Celgene Corp |
Métodos para determinar la eficacia de fármacos usando IKZF3 (AIOLOS)
|
|
US9587281B2
(en)
|
2012-08-14 |
2017-03-07 |
Celgene Corporation |
Cereblon isoforms and their use as biomarkers for therapeutic treatment
|
|
JP5934658B2
(ja)
*
|
2013-01-29 |
2016-06-15 |
Ｊｘエネルギー株式会社 |
イミド−ウレア化合物及びその製造方法、グリース用増ちょう剤並びにグリース組成物
|
|
JP2016506968A
(ja)
|
2013-02-05 |
2016-03-07 |
アントフロゲネシス コーポレーション |
胎盤由来のナチュラルキラー細胞
|
|
US9814555B2
(en)
|
2013-03-12 |
2017-11-14 |
Boston Scientific Scimed, Inc. |
Medical device for pelvic floor repair and method of delivering the medical device
|
|
KR102223060B1
(ko)
|
2013-04-17 |
2021-03-05 |
시그날 파마소티칼 엘엘씨 |
암 치료를 위한 TOR 키나제 억제제 및 ＩＭｉＤ 화합물을 포함하는 조합요법
|
|
US9962251B2
(en)
|
2013-10-17 |
2018-05-08 |
Boston Scientific Scimed, Inc. |
Devices and methods for delivering implants
|
|
EP3142663A1
(en)
|
2014-05-16 |
2017-03-22 |
Celgene Corporation |
Compositions and methods for the treatment of atherosclerotic cardiovascular diseases with pde4 modulators
|
|
EP3827836A1
(en)
|
2014-06-27 |
2021-06-02 |
Celgene Corporation |
Compositions and methods for inducing conformational changes in cereblon and other e3 ubiquitin ligases
|
|
US10682336B2
(en)
|
2015-10-21 |
2020-06-16 |
Amgen Inc. |
PDE4 modulators for treating and preventing immune reconstitution inflammatory syndrome (IRIS)
|
|
US10830762B2
(en)
|
2015-12-28 |
2020-11-10 |
Celgene Corporation |
Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases
|
|
BR112019011025A2
(pt)
|
2016-12-03 |
2019-10-08 |
Juno Therapeutics Inc |
métodos para modulação de células t car
|
|
PT3618842T
(pt)
|
2017-05-01 |
2024-01-12 |
Juno Therapeutics Inc |
Combinação de uma terapia celular e de um composto imunomodulador
|
|
MX2019014268A
(es)
|
2017-06-02 |
2020-08-03 |
Juno Therapeutics Inc |
Artículos de manufactura y métodos para tratamiento usando terapia celular adoptiva.
|
|
US20220225597A1
(en)
|
2017-06-29 |
2022-07-21 |
Juno Therapeutics, Inc. |
Mouse model for assessing toxicities associated with immunotherapies
|
|
US20200246393A1
(en)
|
2017-09-28 |
2020-08-06 |
Celularity, Inc. |
Tumor suppression using human placenta-derived intermediate natural killer (pink) cells in combination with an antibody
|
|
MA49911A
(fr)
|
2017-11-01 |
2020-06-24 |
Juno Therapeutics Inc |
Anticorps et récepteurs antigéniques chimériques spécifiques de l'antigene de maturation des lymphocytes b
|
|
US12031975B2
(en)
|
2017-11-01 |
2024-07-09 |
Juno Therapeutics, Inc. |
Methods of assessing or monitoring a response to a cell therapy
|
|
KR20200110745A
(ko)
|
2017-12-15 |
2020-09-25 |
주노 쎄러퓨티크스 인코퍼레이티드 |
항 - ｃｃｔ5 결합 분자 및 이의 사용 방법
|
|
US11325907B2
(en)
|
2018-01-29 |
2022-05-10 |
Medshine Discovery Inc. |
Crystal form of 1H-imidazo[4,5-b]pyridine-2(3H)-one compound and preparation process therefor
|
|
WO2019164891A1
(en)
|
2018-02-21 |
2019-08-29 |
Celgene Corporation |
Bcma-binding antibodies and uses thereof
|
|
US12263190B2
(en)
|
2018-11-08 |
2025-04-01 |
Juno Therapeutics, Inc. |
Methods and combinations for treatment and T cell modulation
|
|
AU2019381827A1
(en)
|
2018-11-16 |
2021-06-10 |
Juno Therapeutics, Inc. |
Methods of dosing engineered T cells for the treatment of B cell malignancies
|
|
JP7695882B2
(ja)
|
2018-11-30 |
2025-06-19 |
ジュノー セラピューティクス インコーポレイテッド |
養子細胞療法を用いた処置のための方法
|
|
SG11202107976SA
(en)
|
2019-01-29 |
2021-08-30 |
Juno Therapeutics Inc |
Antibodies and chimeric antigen receptors specific for receptor tyrosine kinase like orphan receptor 1 (ror1)
|
|
CN113527179B
(zh)
*
|
2020-04-13 |
2023-07-07 |
苏州璞正医药有限公司 |
链烃取代异吲哚啉-1,3-二酮类pde4抑制剂及其药物用途
|
|
CN113956190B
(zh)
*
|
2021-10-29 |
2023-05-02 |
大连理工大学 |
可激活肿瘤细胞焦亡的细胞器靶向光敏剂及其制备方法和应用
|
|
KR20250029137A
(ko)
|
2022-06-22 |
2025-03-04 |
주노 쎄러퓨티크스 인코퍼레이티드 |
Cd19-표적화된 car t 세포의 2차 요법을 위한 치료 방법
|
|
EP4611798A1
(en)
|
2022-11-02 |
2025-09-10 |
Celgene Corporation |
Methods of treatment with t cell therapy and immunomodulatory agent maintenance therapy
|